XNAS
ZSTK
Market cap58mUSD
Nov 09, Last price
2.69USD
1D
6.75%
1Q
59.59%
IPO
-99.93%
Name
Flora Growth Corp
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Flora Growth Corp., along with its various subsidiaries, operates as a global enterprise specializing in the cultivation, processing, and advancement of medicinal cannabis and its derived products. The company distributes these offerings to a broad international client base, including pharmacies, medical clinics, and cosmetic companies. Its extensive portfolio encompasses a range of activities and products: Cannabis and Derivatives: This core segment involves the production and supply of medical-grade cannabis oil, alongside a spectrum of cannabis-infused medical and wellness items. Health and Personal Care: They develop and market skincare and beauty products, plant-based pharmaceuticals, phytotherapeutics, and dietary supplements. Furthermore, their offerings include a wide array of cannabidiol (CBD) products like edibles (gummies), topical applications, tinctures, and vaping solutions, as well as general lifestyle wellness items such as bath and body products, pet care, and sports recovery aids. Ancillary and Lifestyle Products: Flora Growth designs and sells loungewear crafted from hemp-derived fabrics and provides accessories for cannabis consumption, personal storage, and travel, catering to both vape and dry herb users. Food and Beverages: The company's diversified operations also include the distribution of juices, gourmet chocolates (featuring exotic fruits coated in chocolate and chocolate bars), and dried fruits, beans, and pulp sourced from Amazonian regions. These items reach consumers through various retail channels, including supermarkets, discount stores, coffee shops, restaurants, and airports. They also manufacture, promote, and distribute other beverage products. Pharmaceutical Initiatives: Flora Growth is involved in creating and distributing pain relief formulations and is actively pursuing the development of a pharmaceutical cannabinoid formula intended for Sars-Cov-2 prevention. Their products are marketed under several distinct brands, including JustCBD, Vessel, Mind Naturals, Mambe, Stardog, Tonino Lamborghini, and Kalaya. Established in 2019, Flora Growth Corp. maintains its corporate headquarters in Toronto, Canada.
Key people
Daniel Reis-Faria
Chief Executive Officer, Director · since 2025
Dany Vaiman
Chief Financial Officer · since 2023
Sammy Dorf
Executive Chairman of the Board · since 2024
Michael Heinrich
Executive Chairman of the Board · since 2025
Manfred Leventhal
Independent Director · since 2024
Harold Wolkin
Independent Director · since 2024
Edward Woo
Independent Director · since 2022
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||